1-67320405-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001374259.2(IL12RB2):āc.37A>Gā(p.Met13Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00252 in 1,613,998 control chromosomes in the GnomAD database, including 87 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M13I) has been classified as Uncertain significance.
Frequency
Consequence
NM_001374259.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IL12RB2 | NM_001374259.2 | c.37A>G | p.Met13Val | missense_variant | 3/17 | ENST00000674203.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IL12RB2 | ENST00000674203.2 | c.37A>G | p.Met13Val | missense_variant | 3/17 | NM_001374259.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0129 AC: 1962AN: 152224Hom.: 42 Cov.: 32
GnomAD3 exomes AF: 0.00357 AC: 897AN: 251240Hom.: 18 AF XY: 0.00244 AC XY: 332AN XY: 135788
GnomAD4 exome AF: 0.00143 AC: 2097AN: 1461656Hom.: 44 Cov.: 31 AF XY: 0.00122 AC XY: 888AN XY: 727144
GnomAD4 genome AF: 0.0130 AC: 1973AN: 152342Hom.: 43 Cov.: 32 AF XY: 0.0126 AC XY: 942AN XY: 74510
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
IL12RB2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 02, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at